ADVANCED NON-SMALL CELL LUNG CANCER
Study of an investigational drug, AG3340, in combination with TaxolŽ
(paclitaxel) and ParaplatinŽ (carboplatin) in patients with advanced
non-small cell lung cancer (NSCLC). This study is being conducted in:
- Buffalo, NY
- Calgary, Alb.
- Edmonton, Alb.
- Orlando, FL
- Scottsdale, AZ
- Winston-Salem, NC
http://www.centerwatch.com/studies/LISTING.HTM
HOpe this info helps
God Bless
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
